These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27842795)

  • 21. [Relevance of toxicological identification of narcotics in hair for maintenance therapy of opiate addicts].
    Karakiewicz B; Kozielec T; Stanaszek R; Piekoszewski W
    Pol Arch Med Wewn; 2003 Apr; 109(4):341-7. PubMed ID: 12931485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al.
    Passik SD; Kirsh KL
    Pain Pract; 2006 Jun; 6(2):69-71. PubMed ID: 17309712
    [No Abstract]   [Full Text] [Related]  

  • 23. Can prescription drug monitoring programs help limit opioid abuse?
    Gugelmann HM; Perrone J
    JAMA; 2011 Nov; 306(20):2258-9. PubMed ID: 22110107
    [No Abstract]   [Full Text] [Related]  

  • 24. The Opioid Epidemic and the Minnesota Board of Medical Practice.
    Waisbren SJ
    Minn Med; 2016; 99(3):39-41. PubMed ID: 27323522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: Empower and educate patients diagnosed with chronic nonmalignant pain.
    Vasudevan SV
    J Pain; 2005 Jan; 6(1):10-1. PubMed ID: 15629413
    [No Abstract]   [Full Text] [Related]  

  • 26. The implications of urine drug testing in pain management.
    Vadivelu N; Chen IL; Kodumudi V; Ortigosa E; Gudin MT
    Curr Drug Saf; 2010 Jul; 5(3):267-70. PubMed ID: 20394568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protocol for addressing acute pain and prescribing opioids.
    Epstein H; Hansen C; Thorson D
    Minn Med; 2014 Apr; 97(4):47-51. PubMed ID: 24868935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up to Nonfatal Opioid Overdoses: More of the Same or an Opportunity for Change?
    Gregg J
    Ann Intern Med; 2016 Jan; 164(1):62-3. PubMed ID: 26720852
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Educational intervention for physicians to address the risk of opioid abuse.
    Pasquale MK; Sheer RL; Mardekian J; Masters ET; Patel NC; Hurwitch AR; Weber JJ; Jorga A; Roland CL
    J Opioid Manag; 2017; 13(5):303-313. PubMed ID: 29199396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeling the pain.
    Nuzback K
    Tex Med; 2015 Jan; 111(1):37-41. PubMed ID: 25624026
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescription narcotic drug abuse: "We have met the enemy and they are ourselves.".
    Pawl R
    Surg Neurol; 2008 May; 69(5):538-41. PubMed ID: 18328542
    [No Abstract]   [Full Text] [Related]  

  • 33. Office-based treatment of opioid-dependent patients.
    Ferner RE; Daniels AM
    N Engl J Med; 2003 Jan; 348(1):81-2; author reply 81-2. PubMed ID: 12510051
    [No Abstract]   [Full Text] [Related]  

  • 34. Office-based treatment of opiate addiction.
    Heit HA; Gourlay DL
    N Engl J Med; 2003 Dec; 349(26):2567-8; author reply 2567-8. PubMed ID: 14695422
    [No Abstract]   [Full Text] [Related]  

  • 35. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid contracts and random drug testing for people with chronic pain - think twice.
    Collen M
    J Law Med Ethics; 2009; 37(4):841-5. PubMed ID: 20122120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Call for Better Opioid Prescribing Training and Education.
    Khidir H; Weiner SG
    West J Emerg Med; 2016 Nov; 17(6):686-689. PubMed ID: 27833673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abuse-deterrent formulations approval reform: Will clinical correctness or real-world results be used to address the nation's opioid crisis: "Noninterference" as a new approval standard.
    Cohen D
    J Opioid Manag; 2017; 13(6):357-362. PubMed ID: 29308582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.